LAVA THERAPEUTICS NV shareholders Q2 2023

LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 17 filers reported holding LAVA THERAPEUTICS NV in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

LAVA THERAPEUTICS NV shareholders Q2 2023
NameSharesValueWeighting ↓
Bruce & Co., Inc. 771,874$1,566,9040.44%
Novo Holdings A/S 2,400,000$4,872,0000.38%
Redmile Group, LLC 2,074,372$4,210,9750.16%
Alpha Wave Global, LP 109,097$221,4670.14%
Artal Group S.A. 200,000$4060.01%
Tower Research Capital LLC (TRC) 11,960$24,2790.00%
OSAIC HOLDINGS, INC. 48$970.00%
PNC FINANCIAL SERVICES GROUP, INC. 65,000$131,9500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 100$2030.00%
GEODE CAPITAL MANAGEMENT, LLC 11,124$22,5810.00%
MILLENNIUM MANAGEMENT LLC 80,374$163,1590.00%
MORGAN STANLEY 10,200$20,7060.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 17,100$34,7130.00%
HRT FINANCIAL LP 10,714$210.00%
SIMPLEX TRADING, LLC 1,142$20.00%
TSFG, LLC 400$10.00%
External links

This page lists LAVA THERAPEUTICS NV's shareholders in Q2 2023. To view LAVA THERAPEUTICS NV's shareholder history, click here.